Intellectual Property Notes

Commonwealth fails in its claim for compensation for PBS expenditure

The Federal Court’s decision in Commonwealth v Sanofi Justice Nicholas’ long-awaited decision in Commonwealth v Sanofi is an Australian …

3D Trade Marks: Further guidance from the CJEU regarding shapes necessary to give a technical result

COVID-19: Pressure Points: The UK Government confirms that it will indemnify ventilator manufacturers against IP infringement claims

The UK will not participate in the UPC confirms IP Minister responding to House of Lords' letter

The impact of COVID-19 on competition law in the pharmaceutical sector

COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)

COVID-19: Pressure Points: A Catalyst for Collaboration (Global)

COVID-19: Pressure points: UK Government disables domain names and social media accounts involved in selling fake or unauthorised COVID-19 products

COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)

Arrow declarations – a step towards obviousness?

UK HC confirms that public interest grounds to refuse or limit an injunction to be used sparingly

COVID-19: Pressure points: COVID Counterfeits - combating counterfeiting, product replacement, misleading advertising and cyber crime in the current crisis